Table: Peptidream -9-MTH group results (IFRS)

PeptiDream

09/11/2023 06:30

Nov 9 (Reuters)- 
              Peptidream Inc. 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2023        Sep 30, 2022     Dec 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales               22.54               11.21            30.00    
                  (+101.1 pct)         (+43.3 pct)      (+11.7 pct) 
  Operating            6.75           loss 426 mln          6.30    
                                                        (-29.8 pct) 
  Pretax               4.66           loss 368 mln          3.70    
                                                        (-44.4 pct) 
  Net                  3.54           loss 186 mln          2.70    
                                                        (-64.3 pct) 
  EPS Basic         27.30 yen         loss 1.44 yen                 
  EPS Diluted       27.27 yen         loss 1.44 yen                 
  Ann Div                                  NIL              NIL     
  -Q2 Div              NIL                 NIL                      
  -Q4 Div                                  NIL              NIL     
 
  NOTE - Peptidream Inc.. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4587.T